Circulating microRNAs for Discriminating Obese Preschoolers at Risk of Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02843139|
Recruitment Status : Completed
First Posted : July 25, 2016
Last Update Posted : July 25, 2016
|Condition or disease|
|Discriminate Obese Children at Risk for Diabetes.|
|Study Type :||Observational|
|Actual Enrollment :||535 participants|
|Official Title:||Circulating microRNAs as Novel Prognostic Biomarkers in Obese Preschoolers at Risk for Type 2 Diabetes in Adulthood|
|Study Start Date :||April 2014|
|Actual Primary Completion Date :||October 2015|
|Actual Study Completion Date :||March 2016|
Children recruiters were categorized into three groups: obesity, overweight and normal control based on World Health Organization child growth standards.
Adults with type 2 diabetes were defined if the individual had a fasting plasma glucose (FPG) level ≥ 7.0 mmol/L.
- It is expected that the identification of circulating miRNAs as potential biomarkers may facilitate to the diagnosis of obese preschoolers at high risk for developing diabetes. [ Time Frame: 50-70 month old ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02843139
|Nanjing Maternal and Child Health Care Hospital Affiliated to Nanjing Medical University|
|Nanjing, Jiangsu, China, 210004|